Agios Pharmaceuticals, Inc. <AGIO.O>: Bofa Global Research Raises Price Objective to $50 from $46
AGIO•Related News
Terrestrial Energy, Ameresco to supply IMSR nuclear power for US Army Aberdeen Proving Ground project
AMRC•
Axon Enterprise: On Sept. 18, Co Issued, Sold $1,150 Million Aggregate Principal Amount Of Its 0% Convertible Senior Notes Due 2031
AXON•
Arcmont Asset Management joins Moody’s Nordics briefing panel on European private credit
MCO•
CN Launches Rail Safety Week 2026
CNI•
Axcelis to sponsor, exhibit at ICSCRM 2026 silicon carbide conference
ACLS•